Article
Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation.
Cancer letters - 18 Sept 2009
Hypes Melissa K, Pirisi Lucia, Creek Kim E
Abstract excerpt
Transforming growth factor-beta (TGF-beta) signaling is disrupted in many cancers, including cervical cancer, leading to TGF-beta resistance. Although initially sensitive, human papillomavirus type 16 (HPV16) immortalized human keratinocytes (HKc/HPV16) become increasingly resistant to the growth inhibitory effects of TGF-beta during in vitro progression to a differentiation resistant phenotype (HKc/DR). We have...
Topics
- Binding Sites
- Cell Transformation, Neoplastic
- Cells, Cultured
- DNA Methylation
- Electrophoretic Mobility Shift Assay
- Human papillomavirus 16
- Humans
- Mutation
- Oncogene Proteins, Viral
- Papillomavirus E7 Proteins
- Promoter Regions, Genetic
- Protein Serine-Threonine Kinases
- RNA, Messenger
